Sujan T. Reddy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sujan T. Reddy has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Sean I. Savitz
Institute for Stroke and Cerebrovascular Diseases McGovern Medical School University of Texas Health Science Center at Houston Texas USA
5 shared publicationsChristy Ankrom
Department of Neurology, Institute for Stroke and Cerebrovascular Disease, University of Texas Health Science Center at Houston
2 shared publicationsJing Zhang
Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston
2 shared publicationsMohammad H. Rahbar
Biostatistics/Epidemiology/Research Design Core Center for Clinical and Translational Sciences University of Texas Health Science Center at Houston Texas USA
2 shared publications- Octavio Arevalo
Louisiana State University Health Sciences Center Shreveport, Shreveport, USA
2 shared publications Tzu-Ching Wu
Department of Neurology, Institute for Stroke and Cerebrovascular Disease, University of Texas Health Science Center at Houston
2 shared publications
Latest Publications
- Open Access
- 22 February 2021
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 8 (4) , 929-937
A meta‐analysis of the global impact of the COVID‐19 pandemic on stroke care & the Houston Experience
Objective: To review the global impact of the COVID‐19 pandemic on stroke care‐metrics and report data from a health system in Houston.Methods: We performed a meta‐analysis of the published literature reporting stroke admissions, intracerebral hemorrhage (ICH) cases, number of thrombolysis (tPA) and thrombectomy (MT) cases, and time metrics (door to needle, DTN; and door to groin time, DTG) during the pandemic compared to prepandemic period. Within our hospital system, between January–June 2019 and January–June 2020, we compared the proportion of stroke admissions and door to tPA and MT times.Results: A total of 32,640 stroke admissions from 29 studies were assessed. Compared to prepandemic period, the mean ratio of stroke admissions during the pandemic was 70.78% [95% CI, 65.02%, 76.54%], ICH cases was 83.10% [95% CI, 71.01%, 95.17%], tPA cases was 81.74% [95% CI, 72.33%, 91.16%], and MT cases was 88.63% [95% CI, 74.12%, 103.13%], whereas DTN time was 104.48% [95% CI, 95.52%, 113.44%] and DTG was 104.30% [95% CI, 81.99%, 126.61%].In Houston, a total of 4808 cases were assessed. There was an initial drop of ~30% in cases at the pandemic onset. Compared to 2019, there was a significant reduction in mild strokes (NIHSS 1‐5) [N (%), 891 (43) vs 635 (40), P = 0.02]. There were similar mean (SD) (mins) DTN [44 (17) vs 42 (17), P = 0.14] but significantly prolonged DTG times [94 (15) vs 85 (20), P = 0.005] in 2020.Interpretation: The COVID‐19 pandemic led to a global reduction in stroke admissions and treatment interventions and prolonged treatment time metrics.
- 22 February 2021
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 8 (4) , 929-937
Open AccessA meta‐analysis of the global impact of the COVID‐19 pandemic on stroke care & the Houston Experience
Objective: To review the global impact of the COVID‐19 pandemic on stroke care‐metrics and report data from a health system in Houston.Methods: We performed a meta‐analysis of the published literature reporting stroke admissions, intracerebral hemorrhage (ICH) cases, number of thrombolysis (tPA) and thrombectomy (MT) cases, and time metrics (door to needle, DTN; and door to groin time, DTG) during the pandemic compared to prepandemic period. Within our hospital system, between January–June 2019 and January–June 2020, we compared the proportion of stroke admissions and door to tPA and MT times.Results: A total of 32,640 stroke admissions from 29 studies were assessed. Compared to prepandemic period, the mean ratio of stroke admissions during the pandemic was 70.78% [95% CI, 65.02%, 76.54%], ICH cases was 83.10% [95% CI, 71.01%, 95.17%], tPA cases was 81.74% [95% CI, 72.33%, 91.16%], and MT cases was 88.63% [95% CI, 74.12%, 103.13%], whereas DTN time was 104.48% [95% CI, 95.52%, 113.44%] and DTG was 104.30% [95% CI, 81.99%, 126.61%].In Houston, a total of 4808 cases were assessed. There was an initial drop of ~30% in cases at the pandemic onset. Compared to 2019, there was a significant reduction in mild strokes (NIHSS 1‐5) [N (%), 891 (43) vs 635 (40), P = 0.02]. There were similar mean (SD) (mins) DTN [44 (17) vs 42 (17), P = 0.14] but significantly prolonged DTG times [94 (15) vs 85 (20), P = 0.005] in 2020.Interpretation: The COVID‐19 pandemic led to a global reduction in stroke admissions and treatment interventions and prolonged treatment time metrics.
- 1 January 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (1) , 105418
Lack of Racial, Ethnic, and Sex Disparities in Ischemic Stroke Care Metrics within a Tele-Stroke Network
- 1 January 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (1) , 105418
Lack of Racial, Ethnic, and Sex Disparities in Ischemic Stroke Care Metrics within a Tele-Stroke Network
- 20 September 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (12) , 105308
Rapid Infarct Progression in Anterior Circulation Large Vessel Occlusion Ischemic Stroke Patients During Inter-Facility Transfer
- 20 September 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (12) , 105308
Rapid Infarct Progression in Anterior Circulation Large Vessel Occlusion Ischemic Stroke Patients During Inter-Facility Transfer
- 20 September 2020
- Published by SAGE Publications in Journal of Telemedicine and Telecare
- Vol. 28 (8) , 595-602
Patients transferred within a telestroke network for large-vessel occlusion
Introduction: In a telestroke network, patients at a referring hospital (RH) with large-vessel occlusion (LVO) are transferred to a comprehensive stroke centre (CSC) for endovascular thrombectomy (EVT). However, a significant number of patients do not ultimately undergo thrombectomy after CSC arrival. Methods: Within a 17-hospital telestroke network, we retrospectively analysed patients with suspected or confirmed LVO transferred to a CSC, and characterized the reasons why these patients did not undergo EVT based on the 2019 American Heart Association guidelines. Results: Of 400 patients transferred to our hub, 68 (17%) were based on vascular imaging at RH. Time from RH arrival to neuroimaging was significantly longer in patients that underwent both computed tomography (CT) and CT angiography of the brain and neck compared to only CT of the brain (53 vs 13 minutes, p < 0.05). Accuracy of anterior circulation LVO (ACLVO) detection based on clinical suspicion was 62% (205 of 332 patients). Among 234 ACLVO patients, overall, 175 (74%) (early window group: 123 (73%) patients and late window group: 52 (80%) patients) met at least one EVT ineligibility criterion. The reasons for EVT ineligibility varied from large core infarct (aspects 70 cc on perfusion imaging in late window), low National Institutes of Health Stroke Scale (1). Discussion: Instituting rapid acquisition and interpretation of vascular imaging at RHs for LVO detection and establishing benchmarks for door to vascular imaging is urgently needed for RHs.
- 20 September 2020
- Published by SAGE Publications in Journal of Telemedicine and Telecare
- Vol. 28 (8) , 595-602
Patients transferred within a telestroke network for large-vessel occlusion
Introduction: In a telestroke network, patients at a referring hospital (RH) with large-vessel occlusion (LVO) are transferred to a comprehensive stroke centre (CSC) for endovascular thrombectomy (EVT). However, a significant number of patients do not ultimately undergo thrombectomy after CSC arrival. Methods: Within a 17-hospital telestroke network, we retrospectively analysed patients with suspected or confirmed LVO transferred to a CSC, and characterized the reasons why these patients did not undergo EVT based on the 2019 American Heart Association guidelines. Results: Of 400 patients transferred to our hub, 68 (17%) were based on vascular imaging at RH. Time from RH arrival to neuroimaging was significantly longer in patients that underwent both computed tomography (CT) and CT angiography of the brain and neck compared to only CT of the brain (53 vs 13 minutes, p < 0.05). Accuracy of anterior circulation LVO (ACLVO) detection based on clinical suspicion was 62% (205 of 332 patients). Among 234 ACLVO patients, overall, 175 (74%) (early window group: 123 (73%) patients and late window group: 52 (80%) patients) met at least one EVT ineligibility criterion. The reasons for EVT ineligibility varied from large core infarct (aspects 70 cc on perfusion imaging in late window), low National Institutes of Health Stroke Scale (1). Discussion: Instituting rapid acquisition and interpretation of vascular imaging at RHs for LVO detection and establishing benchmarks for door to vascular imaging is urgently needed for RHs.
- Open Access
- 10 September 2020
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 12 (3) , 266-269
Hypertension-Related Cerebral Microbleeds
Hypertension and cerebral amyloid angiopathy are the most common causes of cerebral microbleeds. The pattern of microbleeds on T2*-weighted gradient echo sequence of magnetic resonance imaging of the brain can be indicative of the etiology of intracerebral hemorrhage. We describe a case of cerebellar hemorrhage with cerebral microbleeds secondary to chronic hypertension.
- 10 September 2020
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 12 (3) , 266-269
Open AccessHypertension-Related Cerebral Microbleeds
Hypertension and cerebral amyloid angiopathy are the most common causes of cerebral microbleeds. The pattern of microbleeds on T2*-weighted gradient echo sequence of magnetic resonance imaging of the brain can be indicative of the etiology of intracerebral hemorrhage. We describe a case of cerebellar hemorrhage with cerebral microbleeds secondary to chronic hypertension.
- Open Access
- 11 June 2020
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 12 (2) , 199-209
Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series
COVID-19 has been associated with a hypercoagulable state causing cardiovascular and neurovascular complications. To further characterize cerebrovascular disease (CVD) in COVID-19, we review the current literature of published cases and additionally report the clinical presentation, laboratory and diagnostic testing results of 12 cases with COVID-19 infection and concurrent CVD from two academic medical centers in Houston, TX, USA, between March 1 and May 10, 2020. To date, there are 12 case studies reporting 47 cases of CVD in COVID-19. However, only 4 small case series have described the clinical and laboratory findings in patients with COVID-19 and concurrent stroke. Viral neurotropism, endothelial dysfunction, coagulopathy and inflammation are plausible proposed mechanisms of CVD in COVID-19 patients. In our case series of 12 patients, 10 patients had an ischemic stroke, of which 1 suffered hemorrhagic transformation and two had intracerebral hemorrhage. Etiology was determined to be embolic without a clear cause identified in 6 ischemic stroke patients, while the remaining had an identifiable source of stroke. The majority of the patients had elevated inflammatory markers such as D-dimer and interleukin-6. In patients with embolic stroke of unclear etiology, COVID-19 may have played a direct or indirect role in the processes that eventually led to the strokes while in the remaining cases, it is unclear if infection contributed partially or was an incidental finding.
- 11 June 2020
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 12 (2) , 199-209
Open AccessCerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series
COVID-19 has been associated with a hypercoagulable state causing cardiovascular and neurovascular complications. To further characterize cerebrovascular disease (CVD) in COVID-19, we review the current literature of published cases and additionally report the clinical presentation, laboratory and diagnostic testing results of 12 cases with COVID-19 infection and concurrent CVD from two academic medical centers in Houston, TX, USA, between March 1 and May 10, 2020. To date, there are 12 case studies reporting 47 cases of CVD in COVID-19. However, only 4 small case series have described the clinical and laboratory findings in patients with COVID-19 and concurrent stroke. Viral neurotropism, endothelial dysfunction, coagulopathy and inflammation are plausible proposed mechanisms of CVD in COVID-19 patients. In our case series of 12 patients, 10 patients had an ischemic stroke, of which 1 suffered hemorrhagic transformation and two had intracerebral hemorrhage. Etiology was determined to be embolic without a clear cause identified in 6 ischemic stroke patients, while the remaining had an identifiable source of stroke. The majority of the patients had elevated inflammatory markers such as D-dimer and interleukin-6. In patients with embolic stroke of unclear etiology, COVID-19 may have played a direct or indirect role in the processes that eventually led to the strokes while in the remaining cases, it is unclear if infection contributed partially or was an incidental finding.
- 1 March 2018
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 75 (3) , 373
Atypical Cause of “Typical” Hypertensive Intracranial Bleeding
A man in his 50s with no known medical history presented with acute left hemiplegia. Noncontrast computed tomography of the head revealed right putamenal and intraventricular hemorrhage (Figure, A). Blood pressure at presentation was 211/100 mm Hg, without evidence of chronic hypertension on echocardiogram or electrocardiogram. Computed tomography angiography of the brain revealed occlusion of the right middle cerebral artery (MCA) with abnormal surrounding vasculature. Digital subtraction angiography demonstrated proximal MCA occlusion with dysplastic lenticulostriate branches serving as bypass to the distal-M1 MCA segment (Figure, B), suggesting that the cause of the hemorrhage was dysplastic vessel rupture. He was treated with blood pressure reduction medication, and an MCA bypass was planned to reduce flow in the dysplastic vessels.
- 1 March 2018
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 75 (3) , 373
Atypical Cause of “Typical” Hypertensive Intracranial Bleeding
A man in his 50s with no known medical history presented with acute left hemiplegia. Noncontrast computed tomography of the head revealed right putamenal and intraventricular hemorrhage (Figure, A). Blood pressure at presentation was 211/100 mm Hg, without evidence of chronic hypertension on echocardiogram or electrocardiogram. Computed tomography angiography of the brain revealed occlusion of the right middle cerebral artery (MCA) with abnormal surrounding vasculature. Digital subtraction angiography demonstrated proximal MCA occlusion with dysplastic lenticulostriate branches serving as bypass to the distal-M1 MCA segment (Figure, B), suggesting that the cause of the hemorrhage was dysplastic vessel rupture. He was treated with blood pressure reduction medication, and an MCA bypass was planned to reduce flow in the dysplastic vessels.
- 22 July 2017
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 17 (9) , 67
Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal
An 80-year-old man presents with an acute right hemiparesis and National Institutes of Health Stroke Scale (NIHSS) of 25, 14 h after taking dabigatran. Activated partial thromboplastin time (aPTT) is 42.8 s. Arteriogram demonstrates left internal carotid artery thrombosis. What is the appropriate management of this patient with acute ischemic stroke while on a NOAC?
- 22 July 2017
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 17 (9) , 67
Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal
An 80-year-old man presents with an acute right hemiparesis and National Institutes of Health Stroke Scale (NIHSS) of 25, 14 h after taking dabigatran. Activated partial thromboplastin time (aPTT) is 42.8 s. Arteriogram demonstrates left internal carotid artery thrombosis. What is the appropriate management of this patient with acute ischemic stroke while on a NOAC?
- Open Access
- 3 June 2017
- Published by Taylor & Francis in OncoImmunology
- Vol. 6 (6) , e1321187
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study
The low response rates to immunotherapy in uveal melanoma (UM) sharply contrast with reputable response rates in cutaneous melanoma (CM) patients. To characterize the mechanisms responsible for resistance to immunotherapy in UM, we performed immune profiling in tumors from 10 metastatic UM patients and 10 metastatic CM patients by immunohistochemistry (IHC). Although there is no difference in infiltrating CD8+ T cells between UM and CM, a significant decrease in programmed death-1 (PD-1)-positive lymphocytes was observed and lower levels of programmed death ligand-1 (PD-L1) in UM metastases compared with CM metastases. Tumors from metastatic UM patients showed a lower success rate of tumor-infiltrating lymphocyte (TIL) growth compared with metastatic CM (45% vs. 64% success), with a significantly lower quantity of UM TIL expanded overall. These studies suggest that UM and CM are immunologically distinct, and provide potential explanation for the impaired success of immunotherapy in UM.
- 3 June 2017
- Published by Taylor & Francis in OncoImmunology
- Vol. 6 (6) , e1321187
Open AccessParallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study
The low response rates to immunotherapy in uveal melanoma (UM) sharply contrast with reputable response rates in cutaneous melanoma (CM) patients. To characterize the mechanisms responsible for resistance to immunotherapy in UM, we performed immune profiling in tumors from 10 metastatic UM patients and 10 metastatic CM patients by immunohistochemistry (IHC). Although there is no difference in infiltrating CD8+ T cells between UM and CM, a significant decrease in programmed death-1 (PD-1)-positive lymphocytes was observed and lower levels of programmed death ligand-1 (PD-L1) in UM metastases compared with CM metastases. Tumors from metastatic UM patients showed a lower success rate of tumor-infiltrating lymphocyte (TIL) growth compared with metastatic CM (45% vs. 64% success), with a significantly lower quantity of UM TIL expanded overall. These studies suggest that UM and CM are immunologically distinct, and provide potential explanation for the impaired success of immunotherapy in UM.